title: Association of race with complications and prognosis following acute coronary syndromes.
abstract: The baseline characteristics, complications, and survival of 489 black and 6,890 non-black patients with acute coronary syndromes were studied. Important racial differences were observed in demographic features, atherosclerosis risk factors, and treatment strategies; however, despite these differences, no independent difference was observed in clinical outcomes according to race. The 1-year mortality rate was 2.9% for black patients and 2.5% for non-black patients (p = 0.93).
authors.affiliation: Department of Cardiology, The Cleveland Clinic Foundation, Weston, Florida, USA.
authors.forename: Craig R
authors.initials: CR
authors.lastname: Asher
authors.forename: David J
authors.initials: DJ
authors.lastname: Moliterno
authors.forename: Manjushri V
authors.initials: MV
authors.lastname: Bhapkar
authors.forename: Darren K
authors.initials: DK
authors.lastname: McGuire
authors.forename: Sunil V
authors.initials: SV
authors.lastname: Rao
authors.forename: David R
authors.initials: DR
authors.lastname: Holmes
authors.forename: L Kristin
authors.initials: LK
authors.lastname: Newby
authors.forename: Eric R
authors.initials: ER
authors.lastname: Bates
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Topol
mesh_terms: D000208:Acute Disease; D001741:Black or African American; D000368:Aged; D003327:Coronary Disease / Q000150:complications* / Q000188:drug therapy / Q000208:ethnology* / Q000401:mortality; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D010091:Oximes / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D010091:Oximes; D010880:Piperidines; D010975:Platelet Aggregation Inhibitors; C100917:sibrafiban